These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 346283)

  • 1. Clinical pharmacokinetics of methotrexate.
    Shen DD; Azarnoff DL
    Clin Pharmacokinet; 1978; 3(1):1-13. PubMed ID: 346283
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacokinetics of methotrexate in psoriasis therapy.
    Hendel J
    Dan Med Bull; 1985 Dec; 32(6):329-37. PubMed ID: 3908004
    [No Abstract]   [Full Text] [Related]  

  • 3. Methotrexate in erythrocytes of patients with psoriasis.
    Schrøder H; Foged EK
    Eur J Clin Pharmacol; 1986; 30(4):453-6. PubMed ID: 3743621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary model for methotrexate pharmacokinetics.
    Bischoff KB; Dedrick RL; Zaharko DS
    J Pharm Sci; 1970 Feb; 59(2):149-54. PubMed ID: 5411336
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis.
    Furst DE
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():11-4. PubMed ID: 3913770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology and clinical use of methotrexate.
    Jolivet J; Cowan KH; Curt GA; Clendeninn NJ; Chabner BA
    N Engl J Med; 1983 Nov; 309(18):1094-104. PubMed ID: 6353235
    [No Abstract]   [Full Text] [Related]  

  • 7. Methotrexate pharmacokinetics in psoriatic patients developing hepatic fibrosis.
    Jones SK; Aherne GW; Campbell MJ; White JE
    Arch Dermatol; 1986 Jun; 122(6):666-9. PubMed ID: 3717976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of therapeutic doses of methotrexate in body fluids of patients with psoriasis.
    Noble WC; White PM; Baker H
    J Invest Dermatol; 1975 Feb; 64(2):69-76. PubMed ID: 1123553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate in psoriasis with and without leucovorin: effect of different dosage schedules on acute liver toxicity.
    Zachariae H; Bjerring P
    Acta Derm Venereol; 1982; 62(5):446-8. PubMed ID: 6183902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic pharmacokinetics of glutaraldehyde-treated methotrexate-loaded carrier erythrocytes in dogs.
    DeLoach JR; Tangner CH; Barton C
    Res Exp Med (Berl); 1983; 183(3):167-75. PubMed ID: 6417745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate for psoriasis. A new therapeutic schedule.
    Weinstein GD; Frost P
    Arch Dermatol; 1971 Jan; 103(1):33-8. PubMed ID: 5539502
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of small doses of methotrexate in patients with psoriasis.
    Kamel RS; al-Hakiem MH; Rademaker M; Meyrick Thomas RH; Munro DD
    Acta Derm Venereol; 1988; 68(3):267-70. PubMed ID: 2455425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the distribution of methotrexate in the sting rays Dasyatidae sabrina and sayi by use of a model developed in mice.
    Zaharko DS; Dedrick RL; Oliverio VT
    Comp Biochem Physiol A Comp Physiol; 1972 May; 42(1):183-94. PubMed ID: 4402707
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical and pathophysiological rationale for amethopterin in psoriasis.
    Weinstein GD
    Ann N Y Acad Sci; 1971 Nov; 186():452-66. PubMed ID: 5289429
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood levels of methotreate and the treatment of psoriasis.
    Halprin KM; Fukui K; Okawara A
    Arch Dermatol; 1971 Mar; 103(3):243-9. PubMed ID: 5107871
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study.
    Gisondi P; Giglio MD; Girolomoni G
    J Dermatolog Treat; 2006; 17(3):172-5. PubMed ID: 16854760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of route of administration and effusions on methotrexate pharmacokinetics.
    Wan SH; Huffman DH; Azarnoff DL; Stephens R; Hoogstraten B
    Cancer Res; 1974 Dec; 34(12):3487-91. PubMed ID: 4429965
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study.
    Bjerring P; Beck HI; Zachariae H; Søgaard H
    Acta Derm Venereol; 1986; 66(6):515-9. PubMed ID: 2433872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption and local action of methotrexate in human and mouse skin.
    Stewart WD; Wallace SM; Runikis JO
    Arch Dermatol; 1972 Sep; 106(3):357-61. PubMed ID: 5055095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.